Drug treatment of epilepsy in the century of the ILAE: The second 50 years, 1959–2009

@article{Shorvon2009DrugTO,
  title={Drug treatment of epilepsy in the century of the ILAE: The second 50 years, 1959–2009},
  author={Simon D. Shorvon},
  journal={Epilepsia},
  year={2009},
  volume={50}
}
  • S. Shorvon
  • Published 1 March 2009
  • Medicine, Psychology
  • Epilepsia
The drug therapy of epilepsy evolved enormously in this 50 year period. Advances in therapeutics included the incorporation of pharmacokinetics into clinical practice, enormous advances in neurochemistry, a trend to antiepileptic drug monotherapy, better drug assessment, better understanding of therapeutic outcomes, and the recognition of the large epilepsy treatment gap in many countries. An unprecedented range of new drugs was introduced in this period. Before 1989, these included… 

The use of recently approved antiepileptic drugs: use with caution, use in refractory patients or use as first-line indications?

TLDR
Despite the development of several new antiepileptic drugs, the efficacy and tolerability of drug treatment of epilepsy has not substantially improved in terms of effectiveness and risk–benefit and cost–benefit profiles.

General Considerations in the Treatment of the Patient with Epilepsy

TLDR
The current antiepileptic therapy is Revista Habanera de Ciencias Médicas ISSN 1729-519X Página 1060 symptomatic and not curative, being necessary to keep in mind the general aspects in the management of the epileptic patient, in an integral and individualized way.

Antiepileptic Drugs Under Investigation for Treatment of Focal Epilepsy

TLDR
This work reports the available data about different classes of molecules that are in the pipeline for treatment of focal epilepsy and reports the results on clinical trials performed with new compounds identified through the investigation of additional molecular targets.

Highights in the History of Epilepsy: The Last 200 Years

The purpose of this study was to present the evolution of views on epilepsy as a disease and symptom during the 19th and the 20th century. A thorough study of texts, medical books, and reports along

A Systematic Review on Etiology of Epilepsy and Recent Advances in Its Treatment

TLDR
This review focuses on the newer treatment modalities and possible beneficial effect of this regimen and limitations of such use.

The evolution of antiepileptic drug development and regulation

TLDR
Changes in approach to antiepileptic drug development reflect a more patient-centric approach to treatment, since it is now recognised that epilepsy can only be effectively managed if patients’ individual real-life needs are addressed, since a key to successful treatment is long-term compliance.

Treatment of epilepsy in daily clinical practice: have outcomes improved over the past 10 years?

TLDR
No evidence is found that in this community the QoL of epilepsy patients has improved in the last decade, despite unrestricted availability of healthcare resources, including accessibility to new AEDs.

Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma

TLDR
The authors of this critical review will discuss several new ideas that may hopefully lead to more efficacious drug treatment of epilepsy in the future.

Epilepsy : A Complex Disease with Several Potential Therapeutic Targets Epilepsy and pharmacogenetics

TLDR
The lack of substantial and long-lasting relief of unprovoked seizures, regardless of the introduction in the past 15 years of secondgeneration antiepileptic drugs (AEDs), epitomizes the necessity of a paradigm shift including a massive effort in the clarification of certain genetic determinants of this chronic neurological disorder.
...

References

SHOWING 1-10 OF 272 REFERENCES

Principles for Clinical Testing of Antiepileptic Drugs

  • J. Penry
  • Medicine, Psychology
    Epilepsia
  • 1973
TLDR
These principles are intended to improve the quality of the clinical evaluation of new antiepileptic drugs and to facilitate the international exchange of data supporting the investigation of new anti-epileptic agents, resulting in the more rapiddevelopment and precise use of new drugs for the treatment of epilepsy.

Ethosuximide in the treatment of epilepsy.

TLDR
The third succinimide, ethosuximide (Zarontin), was found to be highly protective against pentylenetetrazol (Metrazol)-induced seizures in experimental animals.

Monotherapy or Polytherapy for Epilepsy?

  • A. Guberman
  • Medicine, Psychology
    Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
  • 1998
TLDR
The theoretical advantages of monotherapy and monotherapy with traditional and newer AEDs are reviewed, taking advantage of possible synergism, a yet unproven concept.

Results of treatment changes in patients with apparently drug‐resistant chronic epilepsy

TLDR
The aim of this study was to quantify the effect of adding a previously unused antiepileptic drug to the treatment regimen in adults with uncontrolled chronic epilepsy that had been resistant to previous antIEpileptic drug treatment.

We Live in the Age of the Clinical Guideline

  • S. Shorvon
  • Medicine, Political Science
    Epilepsia
  • 2006
TLDR
The intention is to put the case for the opposition and to articulate the negative, to incite critical thought and to sound an alarm on the general issue of guidelines and on the broader consequences of the authors' “guideline” culture.

Double-blind study of vigabatrin in the treatment of drug-resistant epilepsy.

TLDR
The results demonstrate the efficacy and good tolerability of vigabatrin therapy in patients with severe complex partial epilepsy and show a significant reduction in seizure frequency during treatment.

The temporal aspects of prognosis in epilepsy.

  • S. Shorvon
  • Medicine, Psychology
    Journal of neurology, neurosurgery, and psychiatry
  • 1984
TLDR
In this paper prognostic studies in a variety of areas are reviewed to emphasise this point that the traditional view of epilepsy as a chronic condition with a continuing tendency to relapse is not tenable for the majority of patients.

Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study.

TLDR
Vigabatrin seems to be an effective and safe antiepileptic drug as primary monotherapy for epilepsy with fewer cognitive side effects than carbamazepine and Retrieval from both episodic and semantic memory and flexibility of mental processing improved significantly in patients successfully treated with vigab atrin.

Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study.

TLDR
It is concluded that half the patients with childhood-onset epilepsy will eventually enter terminal remission without relapse and a fifth after relapse, and one-third will have a poor long-term outcome in terms of persistent seizures after remission or without any remission ever.
...